OYSTER POINT PHARMA I, LLC 3
3 · Oyster Point Pharma, Inc. · Filed Oct 30, 2019
Insider Transaction Report
Form 3
OYSTER POINT PHARMA I, LLC
10% Owner
Holdings
Series B Convertible Preferred Stock
→ Common Stock, par value $0.001 per share (955,392 underlying)
Footnotes (2)
- [F1]These shares of Series B Convertible Preferred Stock will automatically be converted into shares of the Issuer's Common Stock, on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series B Convertible Preferred Stock has no expiration date.
- [F2]Consists of 955,392 shares of common stock beneficially owned by Oyster Point Pharma I, LLC. William J. Link, as a managing partner of Oyster Point Pharma I, LLC, may be deemed to share voting and dispositive power over the shares held by Oyster Point Pharma I, LLC.